Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they will commission an independent inquiry into how hip replacements containing cobalt have affected the lives of patients.

The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to ensuring that all medical devices on the United Kingdom’s market meet stringent safety and performance standards. It continuously monitors the safety of orthopaedic implants using data from adverse incident reports, national registries, and clinical input to identify emerging risks.

Currently, the MHRA has not identified a safety signal to suggest that cobalt chrome components used more broadly in hip replacements pose an increased or unacceptable risk to patients. Therefore, there are no plans to commission an independent inquiry into hip replacements containing cobalt chrome.